Open access
Oral Semaglutide in Routine Clinical Practice: 24‐Month Real‐World Effectiveness, Persistence and Safety in Adults With Type 2 Diabetes
M. P. A. Baldassarre
G. Di Dalmazi
Federica Carrieri
Giorgia Centorame
Luigi Piacentino
S. Coluzzi
Gloria Formoso
Sep 2026 · Diabetes, obesity and metabolism · Vol 28, pp. 11702 - 11709 · 0 citations
· 9 references
Medicine
Abstract
Real‐world long‐term data on oral semaglutide are limited. We evaluated its 24‐month effectiveness, persistence, and safety in adults with type 2 diabetes (T2D).